Relpax Dual Release Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 18 years ago on Friday, October 21, 2005, according to the United State Patent & Trademark Office

Word Mark	Relpax Dual Release
Status	Dead 606 — Abandoned - No Statement of Use Filed

Pfizer Inc.
235 East 42nd Street
New York, Ny 10017

Serial Number	78222482
Status Date	Friday, October 21, 2005
Filing Date	Friday, October 21, 2005
Attorney	Stacey Hallerman

Correspondent

Christopher N. Bolinger
Pfizer Inc.
#150/5/25
150 E. 42nd Street
New York NY 10017

Case File Statements

Disclaimer with Predetermined Text	"Dual Release"
Goods & Services	Pharmaceutical Preparation for the Treatment of Migraines

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	6 — Active
Status Date	Friday, March 28, 2003
Primary Code	005

Trademark Timeline

Mar 06 2003

Trademark application filed with USPTO
Aug 27 2003

Assigned To Examiner
Sep 09 2003

Non-Final Action Mailed
Oct 14 2003

Correspondence Received In Law Office
Oct 14 2003

Teas Response To Office Action Received
Dec 01 2003

Approved For Pub - Principal Register
Jan 07 2004

Notice of Publication
Jan 27 2004

Published For Opposition
Apr 20 2004

Noa Mailed - Sou Required From Applicant
Sep 22 2004

Extension 1 Filed
Sep 22 2004

Teas Extension Received
Oct 01 2004

Extension 1 Granted
Apr 07 2005

Extension 2 Granted
Apr 07 2005

Extension 2 Filed
Apr 07 2005

Teas Extension Received
Jun 03 2005

Teas Change of Correspondence Received
Dec 21 2005

Abandonment Notice Mailed - No Use Statement Filed
Dec 21 2005

Abandonment - No Use Statement Filed

Relpax Dual Release Trademark Details

Correspondent

Case File Statements

Classifications

Trademark Timeline

You must be signed in to print.

Once signed in, look for the PDF button.